Company news
Infield Minerals Corp news in 2018
Infield Minerals Corp's news releases, calls and decks from 2018, newest first.
InMed Pharmaceuticals Receives Funding from the Government of Canada to Support Development of Novel Cannabinoid Biosynthesis Program
December 4, 2018
InMed Pharmaceuticals Reports First Quarter Fiscal 2019 Financial Results and Provides R&D and Business Update
November 12, 2018
InMed Pharmaceuticals to Report First Quarter Fiscal 2019 Financial Results and Business Update on November 12, 2018
November 5, 2018
InMed Pharmaceuticals Appoints Michael Woudenberg as Vice President, Chemistry, Manufacturing, and Controls
November 5, 2018
BTV Explores Tech Companies on Investors' Radar
November 1, 2018
InMed Pharmaceuticals to Present at BIO Investor Forum on October 17, 2018
October 10, 2018
InMed Pharmaceuticals Signs Agreement with the National Research Council of Canada for Cannabinoid Biofermentation Process Development and Scale-Up
October 3, 2018
InMed Pharmaceuticals Files PCT Patent Application for the Treatment of Pain with Cannabinoids
September 25, 2018
InMed Pharmaceuticals Reports Fourth Quarter and Full Year Fiscal 2018 Financial Results and Provides R&D and Business Update
September 13, 2018
InMed Pharmaceuticals Announces NSERC Grant to The University of British Columbia in Support of Collaborative R&D Work
September 11, 2018
InMed Files Patent Application for its Cannabinoid Biosynthesis Program
September 10, 2018
InMed Pharmaceuticals to Report Fourth Quarter, and Full Year Fiscal 2018 Financial Results and Business Update on September 13, 2018
September 7, 2018
InMed Pharmaceuticals to Present at the H.C. Wainwright 20th Annual Global Investment Conference
August 31, 2018
InMed to Present at the Canaccord Genuity 38th Annual Growth Conference
August 1, 2018
InMed Pharmaceuticals Announces the Closing of C$14.95 Million Bought Deal Financing including Full Exercise of Underwriter's Over-Allotment Option
June 21, 2018
InMed to Present at the 8th Annual LD Micro Invitational Conference
May 29, 2018
InMed Files Patent Application for INM-085 Glaucoma Program
May 14, 2018
InMed Reports Third Quarter Fiscal 2018 Financial Results and Provides Business Update
May 11, 2018
InMed Appoints Dr. Vikramaditya G. Yadav to Scientific Advisory Board
May 1, 2018
InMed Pharmaceuticals Inc. Opens the Market
April 17, 2018
InMed Rings the Opening Bell at the Toronto Stock Exchange
April 17, 2018
InMed Announces Appointment of Joshua Blacher as Chief Business Officer
April 11, 2018
InMed Pharmaceuticals Announces Graduation to Toronto Stock Exchange
March 23, 2018
InMed Appoints Dr. Eric Hsu as Vice President, Preclinical Research and Development
March 13, 2018
InMed to Present at 30th Annual ROTH Capital Conference
March 12, 2018
InMed Announces Peer-Reviewed Publication in Drug Delivery and Translational Research
March 6, 2018
InMed Receives Conditional Approval to List on the Toronto Stock Exchange
March 2, 2018
InMed Closes Over-Subscribed C$9.4 Million Financing
January 4, 2018